Filing Details

Accession Number:
0000902664-13-003591
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-06 18:01:48
Reporting Period:
2013-11-05
Filing Date:
2013-11-06
Accepted Time:
2013-11-06 18:01:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401667 Puma Biotechnology Inc. PBYI Pharmaceutical Preparations (2834) 770683487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1163846 Adage Capital Partners, L.p. 200 Clarendon Street, 52Nd Floor
Boston MA 02116
No No Yes No
1165408 Adage Capital Partners Gp Llc 200 Clarendon Street, 52Nd Floor
Boston MA 02116
No No Yes No
1403403 Adage Capital Advisors, L.l.c. 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No Yes No
1403404 Robert Atchinson 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No Yes No
1403413 Phillip Gross 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share ("Common Stock") Acquisiton 2013-11-05 280,700 $39.60 5,664,119 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Adage Capital Partners GP, L.L.C., a Delaware limited liability company ("ACPGP"), serves as the general partner of Adage Capital Partners, L.P., a Delaware limited partnership (the "Fund"), and as such has discretion over the portfolio securities beneficially owned by the Fund. Adage Capital Advisors, L.L.C., a Delaware limited liability company ("ACA"), is the managing member of ACPGP and directs ACPGP's operations. Robert Atchinson and Phillip Gross are the managing members of ACPGP and ACA and general partners of the Fund. ACPGP, ACA, Robert Atchinson and Phillip Gross disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.